Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Tracy

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
Clinical Chemistry|March 1, 1987
Precision evaluation of the Olympus "Demand" in clinical useE J Chickering, J J Meunier, J M Scanlon, et al.
The Journal of Biological Chemistry|September 1, 1995
The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individualsR M Camire, M Kalafatis, M Cushman, et al.
Journal of Thrombosis and Haemostasis : JTH|December 23, 2009
Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA studyD Green, C Chan, J Kang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2001
Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American menK Yano, J S Grove, R Chen, et al.
American Journal of Epidemiology|December 1, 1991
The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention TrialL H Kuller, J E Eichner, T J Orchard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999
Hormone replacement therapy, inflammation, and hemostasis in elderly womenM Cushman, E N Meilahn, B M Psaty, et al.
American Journal of Epidemiology|February 7, 2001
Association between physical activity and markers of inflammation in a healthy elderly populationD F Geffken, M Cushman, G L Burke, et al.
The American Journal of Cardiology|October 9, 2001
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal womenB W Walsh, D A Cox, A Sashegyi, et al.
Blood|January 1, 1985
A monoclonal antibody that inhibits activation of human Hageman factor (factor XII)E J Small, J A Katzmann, R P Tracy, et al.
Diabetes Care|October 20, 1999
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis StudyA Festa, R D'Agostino, L Mykkänen, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Clinical Chemistry|March 1, 1987
Precision evaluation of the Olympus "Demand" in clinical useE J Chickering, J J Meunier, J M Scanlon, et al.
The Journal of Biological Chemistry|September 1, 1995
The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individualsR M Camire, M Kalafatis, M Cushman, et al.
Journal of Thrombosis and Haemostasis : JTH|December 23, 2009
Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA studyD Green, C Chan, J Kang, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 9, 2001
Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American menK Yano, J S Grove, R Chen, et al.
American Journal of Epidemiology|December 1, 1991
The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention TrialL H Kuller, J E Eichner, T J Orchard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 9, 1999
Hormone replacement therapy, inflammation, and hemostasis in elderly womenM Cushman, E N Meilahn, B M Psaty, et al.
American Journal of Epidemiology|February 7, 2001
Association between physical activity and markers of inflammation in a healthy elderly populationD F Geffken, M Cushman, G L Burke, et al.
The American Journal of Cardiology|October 9, 2001
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal womenB W Walsh, D A Cox, A Sashegyi, et al.
Blood|January 1, 1985
A monoclonal antibody that inhibits activation of human Hageman factor (factor XII)E J Small, J A Katzmann, R P Tracy, et al.
Diabetes Care|October 20, 1999
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis StudyA Festa, R D'Agostino, L Mykkänen, et al.
Pageof 19